Clinical Research Unit, National Hospital Organization Kurihama Medical and Addiction Center, Yokosuka, Kanagawa, Japan.
Department of Gastroenterology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan.
Carcinogenesis. 2020 Aug 12;41(8):1049-1056. doi: 10.1093/carcin/bgaa022.
Follow-up studies of Japanese patients who had undergone endoscopic resection (ER) for early esophageal squamous cell carcinoma (ESCC) have reported a high prevalence of metachronous SCC in the upper aerodigestive tract (UAT). This prospective multicenter cohort study followed up 330 Japanese patients after ER of ESCC for a median of 49.4 months. The Alcohol Use Disorders Identification Test (AUDIT) for the 12-month period prior to study registration revealed high frequencies of high-risk drinking behaviors: 84 (25.4%) subjects had AUDIT scores of ≥15 points (suspected alcohol dependence) and 121 (36.7%) subjects had AUDIT scores of 8-14 points (hazardous drinking). Seventy-four subjects were metachronously diagnosed with ESCC, and 20 subjects with head and neck SCC (HNSCC). AUDIT scores ≥15 were associated with increases in the total number of HNSCCs per 100 person-years (0.4 for 0-7, 1.2 for 8-14 and 7.1 for ≥15; P < 0.0001). AUDIT scores were progressively associated with the grade of esophageal Lugol-voiding lesions (LVLs), a predictor of field cancerization in the UAT. Both an AUDIT score of ≥15 points and the presence of multiple LVLs were independent predictors of metachronous HNSCC [multivariate hazard ratio (95% confidence interval) = 6.98 (1.31-37.09) and 3.19 (1.19-8.54), respectively]. However, a high AUDIT score was not a predictor of metachronous ESCC. In conclusion, high AUDIT scores were markedly frequent in this population and increased the risk of metachronous HNSCC. The assessment of drinking behavior using the AUDIT and the completion of interventions for alcohol problems should be incorporated into the treatment strategy of ESCC. The name of the clinical trial register and the clinical trial registration number: Japan Esophageal Cohort Study, UMIN000001676.
日本一项针对接受内镜下切除(ER)治疗的早期食管鳞状细胞癌(ESCC)患者的随访研究报告称,上呼吸道(UAT)的同时性 SCC 发生率较高。这项前瞻性多中心队列研究对 330 名接受 ESCC ER 治疗的日本患者进行了中位时间为 49.4 个月的随访。在研究登记前的 12 个月内,使用酒精使用障碍识别测试(AUDIT)发现,高风险饮酒行为的发生率较高:84 名(25.4%)受试者的 AUDIT 评分≥15 分(疑似酒精依赖),121 名(36.7%)受试者的 AUDIT 评分 8-14 分(危险饮酒)。74 名患者被诊断为同时性 ESCC,20 名患者被诊断为头颈部 SCC(HNSCC)。AUDIT 评分≥15 与每 100 人年 HNSCC 总数增加相关(0-7 为 0.4,8-14 为 1.2,≥15 为 7.1;P<0.0001)。AUDIT 评分与食管 Lugol 排空病变(LVLs)的严重程度呈正相关,LVLs 是 UAT 发生癌前病变的预测指标。AUDIT 评分≥15 分和多个 LVLs 均是同时性 HNSCC 的独立预测因素[多变量危险比(95%置信区间)=6.98(1.31-37.09)和 3.19(1.19-8.54)]。然而,高 AUDIT 评分并不是同时性 ESCC 的预测因素。总之,该人群中 AUDIT 评分较高的情况明显较为常见,且增加了同时性 HNSCC 的风险。使用 AUDIT 评估饮酒行为并进行酒精问题干预措施应纳入 ESCC 的治疗策略中。临床试验注册名称和临床试验注册号:日本食管队列研究,UMIN000001676。